InvestorsHub Logo
Followers 0
Posts 82
Boards Moderated 0
Alias Born 03/03/2015

Re: None

Saturday, 10/15/2016 2:53:31 PM

Saturday, October 15, 2016 2:53:31 PM

Post# of 6372
They are looking for patients that fit this description:

"de novo AML patients who are elderly and induction therapy ineligible" (quote from their website)

I don't really know, but it probably does take time to find enough of these people to volunteer for the study. It's possible some of these patients don't want an "experimental" treatment, and we need doctors advising them to participate. With more sites conducting the study, one would think it would go quicker.

Also, it's likely that patients are being dosed now, but BPTH is not so good with the PR so we don't know any details about that. I hope we hear something soon. At the latest, we will hear something at the quarterly report in November.

Stay long! Buy more at these low prices if you can.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News